In fact, the DA treatment of RASF strongly reduced IL-6 and IL-8 release in RASF from patients not treated with biologics [35] but induced migration of synovial fibroblasts from long-treated RA patients [36]. Here, CXCL8 is linked to rheumatoid arthritis.